Xceed Molecular Corp
Recherche - Etobicoke

Our CompanyWhat we doAxela offers a unique portfolio of next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. Our suite of products are specifically targeted at biomarker testing and infectious disease research and designed to facilitate the transition to personalized medicine. Our product line consists of instruments, consumable (sensors, chips and reagents) and applications (biomarker content, methods for analysis and software).HistoryAxela, Inc. (previously Axela Biosensors, Inc.) was spun out of the University of Toronto in 2001 to commercialize diffractive optics technology that offered researchers a simple and rapid approach to understanding protein interactions and develop quantitative assays on a single platform. They are commercialized through distributors in the Life Sciences and Clinical Research markets, and specific applications are licensed to diagnostic or industry segment partners. In 2006, for real-time protein interaction analysis, the dotLab, the company launched its first commercial system, and in the following year it was recognized by Frost and Sullivan with the Protein Assays Innovation Award for North America.